Impact of In‐Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer
Adoption of in-office dispensing by independent urology groups increased oral specialty drug prescriptions for advanced prostate cancer within a group's market.
Authors
- Xiu Liu (ORCID: https://orcid.org/0000-0001-8993-013X)
- Christopher Dall (ORCID: https://orcid.org/0000-0002-2207-0531)
- Vahakn B. Shahinian (ORCID: https://orcid.org/0000-0003-3280-7821)
- Mary Oerline (ORCID: https://orcid.org/0000-0002-0264-6951)
- Samuel R. Kaufman
- Brent K. Hollenbeck
- Megan E. V. Caram
- Arnav Srivastava
- Kassem S. Faraj
Institutions
- University of Michigan (US)
- Massachusetts General Hospital (US)
- VA Ann Arbor Healthcare System (US)
- VA Center for Clinical Management Research (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/cam4.71475
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cancer Institute